back conversion test [Regulatives / Guidelines]

posted by Thair Saleh – Jordan, 2024-07-01 11:42 (206 d 23:50 ago) – Posting: # 24050
Views: 1,061

dear Colleagues


in the case of metabolites, (unstable N-oxides or glucuronide metabolites, lactone-ring structures) found in the drug should always covered by the back conversion test, or there is a limit (2%, 5%, 10%) of the drug if the metabolite exceeds then should be covered.

Complete thread:

UA Flag
Activity
 Admin contact
23,368 posts in 4,908 threads, 1,680 registered users;
95 visitors (0 registered, 95 guests [including 7 identified bots]).
Forum time: 10:32 CET (Europe/Vienna)

The mediocre teacher tells.
The good teacher explains.
The superior teacher demonstrates.
The great teacher inspires.    William Arthur Ward

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5